A carregar...
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
BACKGROUND: The therapeutic options for patients with Multiple Sclerosis (MS) have steadily increased due to the approval of new substances that now supplement traditional first-line agents, demanding a paradigm shift in the assessment of disease activity and treatment response in clinical routine....
Na minha lista:
| Publicado no: | BMC Neurol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4977700/ https://ncbi.nlm.nih.gov/pubmed/27502119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-016-0648-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|